• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Crinetics Pharmaceuticals, Inc. - Common Stock (NQ:CRNX)

    83.78 -0.09 (-0.11%)
    Streaming Delayed Price Updated: 11:37 AM EDT, Jul 30, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 657,886
    Open 83.93
    Bid (Size) 83.78 (1,500)
    Ask (Size) 83.79 (400)
    Prev. Close 83.88
    Today's Range 83.77 - 83.93
    52wk Range 25.83 - 84.00
    Shares Outstanding 54,026,103
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: TriCo Bancshares (Nasdaq – TCBK), Twin Vee PowerCats Co. (Nasdaq -VEEE), Crinetics Pharmaceuticals, Inc. (Nasdaq – CRNX), Element Solutions Inc. (NYSE – ESI)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    News headline image
    Shareholder Alert: Ademi LLP investigates whether Crinetics Pharmaceuticals, Inc. is obtaining a Fair Price for Public Shareholders
    From Ademi LLP
    Via GlobeNewswire

    Performance

    YTD
    +79.3%
    +79.3%
    1 Month
    +126.8%
    +126.8%
    3 Month
    +118.0%
    +118.0%
    6 Month
    +63.3%
    +63.3%
    1 Year
    +186.2%
    +186.2%

    More News

    Read More
    News headline image
    Vertex Pharmaceuticals Just Made a $10 Billion Acquisition Worth Watching ↗
    Via The Motley Fool
    Topics Intellectual Property
    News headline image
    Halper Sadeh LLC is Investigating Whether TCBK, ESI, CRNX, SOLS are Obtaining Fair Deals for their Shareholders
    From Halper Sadeh LLC
    Via GlobeNewswire
    News headline image
    Halper Sadeh LLC is Investigating Whether ESI, CRNX, SOLS are Obtaining Fair Deals for their Shareholders
    From Halper Sadeh LLC
    Via GlobeNewswire
    News headline image
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: TriCo Bancshares (Nasdaq – TCBK), Twin Vee PowerCats Co. (Nasdaq -VEEE), Crinetics Pharmaceuticals, Inc. (Nasdaq – CRNX), Element Solutions Inc. (NYSE – ESI)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    News headline image
    Here's Why Vertex Was Willing to Pay a Premium of More Than 100% for Crinetics Pharmaceuticals ↗
    Via The Motley Fool
    News headline image
    Does Vertex's Acquisition of Crinetics Pharmaceuticals Make the Stock a No-Brainer Buy? ↗
    Via The Motley Fool
    News headline image
    Is This Biotech Stock a Buy Near Its 52-Week High? ↗
    Via The Motley Fool
    News headline image
    Why This Pharmaceutical Stock Jumped Close to 100% This Week ↗
    Via The Motley Fool
    Topics Bonds
    News headline image
    Vertex Pharmaceuticals Just Made a $10 Billion Move. Is the Stock a Buy? ↗
    Via The Motley Fool
    Topics Intellectual Property
    On Thursday, there are stocks with unusual volume. Let's take a look. ↗
    Via Chartmill
    News headline image
    Here's How Much $1000 Invested In Crinetics Pharmaceuticals 5 Years Ago Would Be Worth Today ↗
    Via Benzinga
    News headline image
    Halper Sadeh LLC is Investigating Whether CRNX, ESI, INVE, SLP are Obtaining Fair Deals for their Shareholders
    From Halper Sadeh LLC
    Via GlobeNewswire
    The trading volume of these stocks is deviating from the norm in today's session. ↗
    Via Chartmill
    News headline image
    Crinetics Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Crinetics Pharmaceuticals, Inc. - CRNX
    From Kahn Swick & Foti, LLC
    Via Business Wire
    News headline image
    Vertex’s Crinetics Deal Balances Growth with Integration Risk ↗
    Via MarketBeat
    News headline image
    Vertex Is Paying a 102% Premium to Acquire Crinetics for $10 Billion. Here's Whether the Deal Is Worth It. ↗
    Via The Motley Fool
    News headline image
    Vertex Is Buying Crinetics for $10 Billion. Here's What Investors Need to Know. ↗
    Via The Motley Fool
    Topics Intellectual Property
    Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
    Via Chartmill
    Most active stocks in Tuesday's session ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
    Via Benzinga
    Top stock movements in today's session. ↗
    Via Chartmill
    News headline image
    CRNX Stock Alert: Halper Sadeh LLC is Investigating Whether Crinetics Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders
    From Halper Sadeh LLC
    Via GlobeNewswire
    The market is filled with gapping stocks in Tuesday's session. ↗
    Via Chartmill

    Frequently Asked Questions

    Is Crinetics Pharmaceuticals, Inc. - Common Stock publicly traded?
    Yes, Crinetics Pharmaceuticals, Inc. - Common Stock is publicly traded.
    What exchange does Crinetics Pharmaceuticals, Inc. - Common Stock trade on?
    Crinetics Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Crinetics Pharmaceuticals, Inc. - Common Stock?
    The ticker symbol for Crinetics Pharmaceuticals, Inc. - Common Stock is CRNX on the Nasdaq Stock Market
    What is the current price of Crinetics Pharmaceuticals, Inc. - Common Stock?
    The current price of Crinetics Pharmaceuticals, Inc. - Common Stock is 83.78
    When was Crinetics Pharmaceuticals, Inc. - Common Stock last traded?
    The last trade of Crinetics Pharmaceuticals, Inc. - Common Stock was at 07/30/26 11:37 AM ET
    What is the market capitalization of Crinetics Pharmaceuticals, Inc. - Common Stock?
    The market capitalization of Crinetics Pharmaceuticals, Inc. - Common Stock is 4.53B
    How many shares of Crinetics Pharmaceuticals, Inc. - Common Stock are outstanding?
    Crinetics Pharmaceuticals, Inc. - Common Stock has 5B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.